New Studies Link Rare Blood Clots to Specific COVID-19 Vaccines; AIM Calls for Enhanced Surveillance

May 17, 2024
New Studies Link Rare Blood Clots to Specific COVID-19 Vaccines; AIM Calls for Enhanced Surveillance
  • The Awaken India Movement (AIM) has expressed persistent worries regarding adverse events following COVID-19 vaccinations, highlighting recent academic research.

  • New studies from Banaras Hindu University and Flinders University have reported side effects associated with Covaxin and AstraZeneca's vaccines.

  • Further research pinpoints that rare blood clots from Johnson & Johnson and AstraZeneca vaccines may be caused by an autoimmune reaction in genetically predisposed individuals.

  • Incidence rates include 60 cases of blood clots among over 18 million recipients of the J&J vaccine and 2-3 cases per 100,000 AstraZeneca vaccinations in Australians under 60, with some fatalities.

  • AIM advocates for a governmental reevaluation of the science behind all COVID-19 vaccines and calls for the establishment of rigorous surveillance systems to detect and monitor vaccine-related adverse events.

Summary based on 9 sources


Get a daily email with more Science stories

More Stories